Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
When and where was Neurocept founded and who were its founders?
Executive summary
Available reporting about "Neurocept" is mixed and fragmented: some commercial press releases and multiple retail sites present Neurocept as a newly launched brain‑support supplement in November 2025 (New York City launch claims) while government corporate records show a UK‑registered company named NEUROCEPT LIMITED with filings and an office in Birmingham, England (registered company number 09882135) [1] [2]. Consumer‑protection outlets warn of deceptive marketing and possible scam complaints tied to the Neurocept name [3] [4].
1. What the company claims: a U.S. product launch in November 2025
Several syndicated press pieces and the product’s marketing sites frame Neurocept as a new cognitive‑support supplement entering the U.S. wellness market on or around November 7, 2025, with copy that locates the launch in New York City and touts “clinically inspired” formulation and R&D standards [1] [5] [6]. Those same promotional channels (official product domains) describe Neurocept as a natural, research‑backed dietary supplement for memory, focus and brain health [7] [8] [9].
2. Public corporate records: NEUROCEPT LIMITED registered in the UK
Companies House records identify NEUROCEPT LIMITED (company number 09882135) with a registered office in Birmingham, West Midlands, England — a concrete corporate filing separate from the U.S. marketing narrative [2] [10]. The Companies House filing history page confirms the legal existence of that UK entity but the filings provided in search results do not, by themselves, name the company’s founders or show a U.S. product‑launch claim [10].
3. Consumer complaints and credibility warnings
Better Business Bureau listings and ScamTracker reports link the Neurocept name to complaints alleging false advertising, use of fake or misleading endorsements, and purchases made through social media that consumers later flagged as scams; a specific ScamTracker entry documents a September 1, 2025 purchase complaint for Neurocept product bottles [3] [4]. Trustpilot user reviews also allege that the marketing misused well‑known personalities and, in at least one review, that advertised ingredient lists did not match delivered product claims [11].
4. Discrepancy between marketing and independent records
The materials that most explicitly answer “when and where” — promotional press releases — place Neurocept’s U.S. market debut in November 2025 [1]. Independent, public corporate records instead point to a registered UK company with a Birmingham address [2]. Available sources do not mention a U.S. corporate founding date or a clearly identified founding team for the supplement marketing operation; there is therefore an unresolved mismatch between marketing claims and the UK corporate filing [1] [2]. Available sources do not mention the identities of founders for the U.S. marketing operation.
5. What’s not found in current reporting (limitations)
Search results do not provide a definitive founding date or a named list of founders tying the U.S. supplement marketing (press releases and product sites) to the UK company filings. The press releases and product domains do not list corporate officers or founders in the excerpts returned; Companies House pages referenced show company existence but do not supply founder biographies in the snippets available [1] [2] [10]. Therefore, claims about who founded Neurocept (by individual names) or an exact founding date cannot be firmly established from the provided materials — available sources do not mention those founder names or an explicit foundation date for the product business.
6. Competing perspectives and possible motives
Promotional materials (GlobeNewswire, affiliated outlets) present Neurocept as a science‑based U.S. product launch — likely aimed at building consumer trust and retail momentum [1] [5]. Consumer protection listings and user reviews present an opposing view: customers and watchdogs suspect deceptive advertising, fake endorsements, and problematic fulfillment [3] [4] [11]. That contrast suggests a commercial incentive to maximize market adoption through prominent U.S. launch messaging, while operational or legal registration may be elsewhere — an arrangement sometimes used by supplement sellers to structure fulfillment, payment processing or liability across jurisdictions [1] [2]. Available sources do not explicitly state the company’s motives.
7. What to do next if you need a definitive answer
To establish who founded Neurocept and when, consult primary records not present in these search results: full Companies House filings for NEUROCEPT LIMITED (officer and incorporation documents), WHOIS and corporate registration records for the product domains, and press‑release bylines or published SEC/registry filings if the U.S. entity exists [2] [10]. Because such documents were not in the provided set, available sources do not mention the definitive founding individuals or a chronological founding statement tying the marketing claims to the UK company.
Summary: Promotional material claims a U.S. launch in November 2025 (New York City) while Companies House shows a NEUROCEPT LIMITED registered in Birmingham, UK; consumer watchdogs have flagged suspicious marketing and purchases. The provided sources do not name the company’s founders or give a conclusive founding date linking the marketing to the registered entity [1] [2] [3] [4] [11].